Travere Therapeutics Inc. (TVTX) is ready for next Episode as it posted an annual sales of 227,490 K

Travere Therapeutics Inc. (NASDAQ: TVTX) on January 24, 2023, started off the session at the price of $21.50, soaring 0.37% from the previous trading day. During the day, the shares moved up to $22.11 and dropped to $21.20 before settling in for the closing price of $21.65. Within the past 52 weeks, TVTX’s price has moved between $17.97 and $30.35.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


A company in the Healthcare sector has jumped its sales by 11.20% annually for the last half of the decade. The company achieved an average annual earnings per share of 24.20%. With a float of $63.33 million, this company’s outstanding shares have now reached $64.03 million.

In an organization with 310 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +85.32, operating margin of -61.32, and the pretax margin is -78.98.

Travere Therapeutics Inc. (TVTX) Insider Updates

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The most recent insider transaction that took place on Jan 05, was worth 116,719. In this transaction Chief Executive Officer of this company sold 5,625 shares at a rate of $20.75, taking the stock ownership to the 154,288 shares. Before that another transaction happened on Jan 05, when Company’s Chief Medical Officer sold 442 for $20.75, making the entire transaction worth $9,172. This insider now owns 17,507 shares in total.

Travere Therapeutics Inc. (TVTX) Performance Highlights and Predictions

As on 9/29/2022, Multinational firm has announced its last quarter scores, in which it reported -$1.09 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.86) by -$0.23. This company achieved a net margin of -79.16 while generating a return on equity of -70.17. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.65 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 24.20% per share during the next fiscal year.

Travere Therapeutics Inc. (NASDAQ: TVTX) Trading Performance Indicators

Travere Therapeutics Inc. (TVTX) is currently performing well based on its current performance indicators. A quick ratio of 4.00 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.49.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.18, a number that is poised to hit -0.96 in the next quarter and is forecasted to reach -3.50 in one year’s time.

Technical Analysis of Travere Therapeutics Inc. (TVTX)

Let’s dig in a bit further. During the last 5-days, its volume was 1.17 million. That was better than the volume of 1.09 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 84.58%. Additionally, its Average True Range was 0.97.

During the past 100 days, Travere Therapeutics Inc.’s (TVTX) raw stochastic average was set at 36.12%, which indicates a significant decrease from 86.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.24% in the past 14 days, which was lower than the 47.56% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $20.27, while its 200-day Moving Average is $23.73. However, in the short run, Travere Therapeutics Inc.’s stock first resistance to watch stands at $22.16. Second resistance stands at $22.59. The third major resistance level sits at $23.07. If the price goes on to break the first support level at $21.25, it is likely to go to the next support level at $20.77. Assuming the price breaks the second support level, the third support level stands at $20.34.

Travere Therapeutics Inc. (NASDAQ: TVTX) Key Stats

Market capitalization of the company is 1.39 billion based on 64,174K outstanding shares. Right now, sales total 227,490 K and income totals -180,090 K. The company made 53,500 K in profit during its latest quarter, and -69,660 K in sales during its previous quarter.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

5 Best TaaS Stocks to Buy Right Now

TaaS stock refers to a financial asset sold by...

Iron Mountain Incorporated (IRM) ticks all the boxes for top investors with its surprise performance of 8.62% last month.

Iron Mountain Incorporated (NYSE: IRM) on January 27, 2023, started off the session at the price of $53.64, soaring 2.69% from the previous trading...

KKR & Co. Inc. (KKR) last year’s performance of -13.99% is a clear signal for an entertaining trading season.

January 27, 2023, KKR & Co. Inc. (NYSE: KKR) trading session started at the price of $55.19, that was 0.33% jump from the session...

CenterPoint Energy Inc. (CNP) is ready for next Episode as it posted an annual sales of 8,352 M

On January 27, 2023, CenterPoint Energy Inc. (NYSE: CNP) opened at $29.96, lower -0.87% from the last session. During the day, the shares moved...


Please enter your comment!
Please enter your name here